High efficacy and safety of the combination HCV regimen elbasvir and grazoprevir for 8 weeks in treatment-naive non-severe fibrosis HCVGT1b-infected patients: Final results of the STREAGER study

Affiliation auteurs!!!! Error affiliation !!!!
TitreHigh efficacy and safety of the combination HCV regimen elbasvir and grazoprevir for 8 weeks in treatment-naive non-severe fibrosis HCVGT1b-infected patients: Final results of the STREAGER study
Type de publicationJournal Article
Year of Publication2019
AuteursAbergel A, Hezode C, Asselah T, Larrey D, Gournay J, Loustaud-Ratti V, Di Martino V, Hubert IFouchard, Stanislas P, Bailly F, Samuel D, Albert T, Chanteranne B, Dodel M, Faure F, Pereira B, Lamblin G, Muti L, Campos C, Reymond M, Teilhet C, Buchard B
JournalJOURNAL OF HEPATOLOGY
Volume70
PaginationE207
Date PublishedAPR
Type of ArticleMeeting Abstract
ISSN0168-8278
DOI10.1016/S0618-8278(19)30386-X